Last modified: November 13, 2009
Offices[edit]
- Lynda Chin
People[edit]
Web Presences[edit]
- Biotech & Life Sciences
- Pharmaceutical
Industries[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
- AVEO Pharmaceuticals
- oncology
- kidney cancer
- tivozanib
- cancer research
- cancer drug
- lung cancer
- cancer therapies
- Human Response Platform
- targeted cancer therapy
- renal cell cancer
- VEGF receptor inhibitor
- cancer biology platform
- AV-299
- monoclonal antibodies
- antibody discovery engine
- non-small cell lung cancer
- in vivo mouse models
- TIVO-1 trial
- ErbB3 program
|
|
Description[edit]
AVEO Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of new, targeted cancer therapeutics, with the ultimate goal of developing drugs that will improve the lives of cancer patients. AVEO believes that patients shouldn?t be forced to compromise tolerability for efficacy when evaluating cancer treatment regimens. Through a combination of internal antibody drug discovery and selective in-licensing of targeted small molecule therapies AVEO is committed to bringing safe and effective oncology treatments to patients living with cancer.
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| AVEO Pharmaceuticals Job Trends | AVEO Pharmaceuticals Jobs |
Recent Updates |
|---|
| AVEO Pharmaceuticals has been featured in Women Leaders in Life Sciences event - October 6. |
| Lynda Chin has been added to the company. |
| AVEO Pharmaceuticals has been added to the Ecosystem. |
Leave a Reply
THE COMPANY DESCRIPTION THAT APPEARS ON THIS CAREINNOVATORS PAGE MAY COME FROM AVEOPHARMA.COM. THIS CONTENT IS PROVIDED 'AS IS' AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME.